BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35195571)

  • 21. HPV genotyping in biopsies of HSIL and invasive cervical cancers in women living with HIV: A cohort- and a nested -case control study.
    Gilles C; Rozenberg S; Buxant F; Manigart Y; de Wind R; Houte KV; Vandenbroeck D; Delforge M; Konopnicki D
    Vaccine; 2022 Nov; 40(50):7230-7237. PubMed ID: 36328880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A systematic review of the association between smoking exposure and HPV-related cervical cell abnormality among women living with HIV: Implications for prevention strategies.
    Zhao R; Sekar P; Bennis SL; Kulasingam S
    Prev Med; 2023 May; 170():107494. PubMed ID: 37001607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes in women with biopsy-confirmed cervical intraepithelial neoplasia grade 1 or normal cervix and related cofactors: A 15-year population-based cohort study from China.
    Hu SY; Rezhake R; Chen F; Zhang X; Pan QJ; Ma JF; Qiao YL; Zhao FH
    Gynecol Oncol; 2020 Mar; 156(3):616-623. PubMed ID: 31937451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of age and high-risk human papillomavirus (hrHPV) status on the prevalence of high-grade cervical intraepithelial neoplasia (CIN2+) in women with persistent hrHPV-positive, cytology-negative screening samples: a prospective cohort study.
    Tidy JA; Lyon R; Ellis K; Macdonald M; Palmer JE
    BJOG; 2020 Sep; 127(10):1260-1267. PubMed ID: 32279427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonvaccine human papillomavirus genotype common in women with HIV failing cervical precancer treatment.
    Carlander C; Lagheden C; Eklund C; Nordqvist Kleppe S; Dzabic M; Wagner P; Sparén P; Dillner J
    AIDS; 2021 Nov; 35(14):2367-2374. PubMed ID: 34723851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of high-risk human papillomavirus types and cervical squamous intraepithelial lesions in women over 30 years of age in St. Petersburg, Russia.
    Shipitsyna E; Zolotoverkhaya E; Kuevda D; Nasonova V; Romanyuk T; Khachaturyan A; Orlova O; Abashova E; Kostyuchek I; Shipulina O; Anttila A; Savicheva A
    Cancer Epidemiol; 2011 Apr; 35(2):160-4. PubMed ID: 20884314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-1, HIV-2, human papillomavirus infection and cervical neoplasia in high-risk African women.
    Langley CL; Benga-De E; Critchlow CW; Ndoye I; Mbengue-Ly MD; Kuypers J; Woto-Gaye G; Mboup S; Bergeron C; Holmes KK; Kiviat NB
    AIDS; 1996 Apr; 10(4):413-7. PubMed ID: 8728046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary HPV and Molecular Cervical Cancer Screening in US Women Living With Human Immunodeficiency Virus.
    Strickler HD; Keller MJ; Hessol NA; Eltoum IE; Einstein MH; Castle PE; Massad LS; Flowers L; Rahangdale L; Atrio JM; Ramirez C; Minkoff H; Adimora AA; Ofotokun I; Colie C; Huchko MJ; Fischl M; Wright R; D'Souza G; Leider J; Diaz O; Sanchez-Keeland L; Shrestha S; Xie X; Xue X; Anastos K; Palefsky JM; Burk RD
    Clin Infect Dis; 2021 May; 72(9):1529-1537. PubMed ID: 32881999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of thermal ablation for treatment of biopsy-confirmed high-grade cervical precancer among women living with HIV in Kenya.
    Mungo C; Osongo CO; Ambaka J; Omoto J; Cohen CR
    Int J Cancer; 2023 Dec; 153(12):1971-1977. PubMed ID: 37715464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human papillomavirus infection and cervical dysplasia in HIV-positive women: potential role of the vaginal microbiota.
    van de Wijgert JHHM; Gill AC; Chikandiwa A; Verwijs MC; Kelly HA; Omar T; Delany-Moretlwe S; Segondy M; Francis S; Darby AC; Mayaud P;
    AIDS; 2020 Jan; 34(1):115-125. PubMed ID: 31567164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subtype distribution of human papillomavirus in HIV-infected women with cervical intraepithelial neoplasia stages 2 and 3 in Botswana.
    Ramogola-Masire D; McGrath CM; Barnhart KT; Friedman HM; Zetola NM
    Int J Gynecol Pathol; 2011 Nov; 30(6):591-6. PubMed ID: 21979597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiretroviral Therapy and Detection of High-grade Cervical Intraepithelial Neoplasia (CIN2+) at Post-CIN Management Follow-up Among Women Living With Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis.
    Atemnkeng N; Aji AD; de Sanjose S; Mayaud P; Kelly H
    Clin Infect Dis; 2020 Dec; 71(10):e540-e548. PubMed ID: 32162657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution of Human Papillomavirus (HPV) Genotypes in HIV-Negative and HIV-Positive Women with Cervical Intraepithelial Lesions in the Eastern Cape Province, South Africa.
    Taku O; Mbulawa ZZA; Phohlo K; Garcia-Jardon M; Businge CB; Williamson AL
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33670231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cervical intraepithelial neoplasia and human papillomavirus infection among Senegalese women seropositive for HIV-1 or HIV-2 or seronegative for HIV.
    Seck AC; Faye MA; Critchlow CW; Mbaye AD; Kuypers J; Woto-Gaye G; Langley C; De EB; Holmes KK; Kiviat NB
    Int J STD AIDS; 1994; 5(3):189-93. PubMed ID: 8061090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of cervical intraepithelial neoplasia grade 2+ (CIN2+) using HPV DNA testing after a diagnosis of atypical squamous cell of undetermined significance (ASC-US) in Catalonia, Spain.
    Ibáñez R; Moreno-Crespi J; Sardà M; Autonell J; Fibla M; Gutiérrez C; Lloveras B; Alejo M; Català I; Alameda F; Casas M; Bosch FX; de Sanjosé S
    BMC Infect Dis; 2012 Jan; 12():25. PubMed ID: 22280073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of types 16 and 33 is increased in high-risk human papillomavirus positive women with cervical intraepithelial neoplasia grade 2 or worse.
    Bulkmans NW; Bleeker MC; Berkhof J; Voorhorst FJ; Snijders PJ; Meijer CJ
    Int J Cancer; 2005 Nov; 117(2):177-81. PubMed ID: 15900579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytology and human papillomavirus screening test results associated with 2827 histopathologic diagnoses of cervical intraepithelial neoplasia 2/3.
    Zhao C; Amin M; Weng B; Chen X; Kanbour-Shakir A; Austin RM
    Arch Pathol Lab Med; 2013 Jul; 137(7):942-7. PubMed ID: 23050808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations of RBC and Serum Folate Concentrations with Cervical Intraepithelial Neoplasia and High-Risk Human Papillomavirus Genotypes in Female Chinese Adults.
    Wang W; Yang A; Zhang H; Li Y; Yang J; Zhao W; Wang Z; Lou H; Wang W; Liang T; Zhang L; Su X; Wang C; Wang J; Song J; Li L; Lv W; Zhao C; Hao M
    J Nutr; 2022 Feb; 152(2):466-474. PubMed ID: 35051275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Baseline prevalence and type distribution of human papillomavirus in healthy Chinese women aged 18-25 years enrolled in a clinical trial.
    Zhao FH; Zhu FC; Chen W; Li J; Hu YM; Hong Y; Zhang YJ; Pan QJ; Zhu JH; Zhang X; Chen Y; Tang H; Zhang H; Durand C; Datta SK; Struyf F; Bi D;
    Int J Cancer; 2014 Dec; 135(11):2604-11. PubMed ID: 24740547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carcinoma of the conjunctiva and HIV infection in Uganda and Malawi.
    Waddell KM; Lewallen S; Lucas SB; Atenyi-Agaba C; Herrington CS; Liomba G
    Br J Ophthalmol; 1996 Jun; 80(6):503-8. PubMed ID: 8759259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.